FDA Offers Direction on Dietary Management in IEM Drug Trials

Optimizing dietary management during drug trials is critical to accurately assessing drug efficacy in clinical trials for inborn errors of metabolism (IEM), the FDA says in a new draft guidance.
Source: Drug Industry Daily